DE102010045890A1 - 2,2'-Furoin-Derivte und deren Verwendung zur Hautaufhellung - Google Patents

2,2'-Furoin-Derivte und deren Verwendung zur Hautaufhellung Download PDF

Info

Publication number
DE102010045890A1
DE102010045890A1 DE102010045890A DE102010045890A DE102010045890A1 DE 102010045890 A1 DE102010045890 A1 DE 102010045890A1 DE 102010045890 A DE102010045890 A DE 102010045890A DE 102010045890 A DE102010045890 A DE 102010045890A DE 102010045890 A1 DE102010045890 A1 DE 102010045890A1
Authority
DE
Germany
Prior art keywords
atoms
independently
alk
formula
nyy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE102010045890A
Other languages
German (de)
English (en)
Inventor
Dr. Scheurich René Peter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Priority to DE102010045890A priority Critical patent/DE102010045890A1/de
Priority to CN2011800512377A priority patent/CN103179948A/zh
Priority to PCT/EP2011/004160 priority patent/WO2012034629A1/de
Priority to US13/817,854 priority patent/US8906351B2/en
Priority to JP2013528537A priority patent/JP5731653B2/ja
Priority to EP11752111.2A priority patent/EP2616040B1/de
Publication of DE102010045890A1 publication Critical patent/DE102010045890A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Furan Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE102010045890A 2010-09-17 2010-09-17 2,2'-Furoin-Derivte und deren Verwendung zur Hautaufhellung Withdrawn DE102010045890A1 (de)

Priority Applications (6)

Application Number Priority Date Filing Date Title
DE102010045890A DE102010045890A1 (de) 2010-09-17 2010-09-17 2,2'-Furoin-Derivte und deren Verwendung zur Hautaufhellung
CN2011800512377A CN103179948A (zh) 2010-09-17 2011-08-18 2,2’-联糠醛衍生物及其使皮肤增亮的用途
PCT/EP2011/004160 WO2012034629A1 (de) 2010-09-17 2011-08-18 2,2'-furoin-derivate und deren verwendung zur hautaufhellung
US13/817,854 US8906351B2 (en) 2010-09-17 2011-08-18 2,2′-furoin derivatives and use thereof to light skin
JP2013528537A JP5731653B2 (ja) 2010-09-17 2011-08-18 2,2’−フロイン誘導体および皮膚を明るくするためのその使用
EP11752111.2A EP2616040B1 (de) 2010-09-17 2011-08-18 2,2'-furoin-derivate und deren verwendung zur hautaufhellung

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102010045890A DE102010045890A1 (de) 2010-09-17 2010-09-17 2,2'-Furoin-Derivte und deren Verwendung zur Hautaufhellung

Publications (1)

Publication Number Publication Date
DE102010045890A1 true DE102010045890A1 (de) 2012-03-22

Family

ID=44584120

Family Applications (1)

Application Number Title Priority Date Filing Date
DE102010045890A Withdrawn DE102010045890A1 (de) 2010-09-17 2010-09-17 2,2'-Furoin-Derivte und deren Verwendung zur Hautaufhellung

Country Status (6)

Country Link
US (1) US8906351B2 (cg-RX-API-DMAC7.html)
EP (1) EP2616040B1 (cg-RX-API-DMAC7.html)
JP (1) JP5731653B2 (cg-RX-API-DMAC7.html)
CN (1) CN103179948A (cg-RX-API-DMAC7.html)
DE (1) DE102010045890A1 (cg-RX-API-DMAC7.html)
WO (1) WO2012034629A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014139756A3 (de) * 2013-03-11 2014-12-18 Beiersdorf Ag Verwendung kosmetisch oder dermatologisch un­bedenk­licher substituierter michael-akzeptoren zur verhinderung, verminderung oder prophylaxe der tyrosinaseaktivität der menschlichen haut und/oder deren aufhellung

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8654815B1 (en) 2004-04-02 2014-02-18 Rearden, Llc System and method for distributed antenna wireless communications
JP2015529636A (ja) * 2012-07-03 2015-10-08 コロラド ステート ユニバーシティ リサーチ ファンデーション バイオリファイニング化合物及び有機分子触媒によるアップグレード方法
CN107759542A (zh) * 2017-11-13 2018-03-06 天津工业大学 噻唑类离子液体催化糠醛耦合为糠偶姻
TWI839353B (zh) * 2018-06-28 2024-04-21 德商漢高股份有限及兩合公司 展現低固化溫度之含有潛還原劑的陽離子性可固化組合物

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0487404A1 (en) 1990-11-19 1992-05-27 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo External dermatological composition
WO1993004665A1 (fr) 1991-08-29 1993-03-18 L'oreal Composition cosmetique filtrante contenant un polymere filtre liposoluble a structure hydrocarbonee et une silicone filtre
DE4308282A1 (de) 1993-03-16 1994-09-22 Beiersdorf Ag Vorzugsweise in Form von Mikrosphärulen vorliegende galenische Matrices
WO1996009807A1 (de) 1994-09-27 1996-04-04 Henkel Kommanditgesellschaft Auf Aktien 2-hydroxy-1-ethanon-derivate zum färben keratinhaltiger fasern
DE19704273A1 (de) 1996-03-08 1997-09-11 Basf Ag Verfahren zur katalytischen Herstellung von optisch aktiven Hydroxyketonen
DE10133202A1 (de) 2001-07-07 2003-01-16 Beiersdorf Ag Osmolyte enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
EP1508327A1 (de) 2003-08-18 2005-02-23 MERCK PATENT GmbH Verwendung von Chromen-4-on-Derivaten zur Haut- oder Haarpflege
WO2006111234A1 (de) 2005-04-19 2006-10-26 Merck Patent Gmbh Uv schutz

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0611301B1 (en) * 1990-04-26 2003-06-11 The Procter & Gamble Company Chelator compositions comprising oxime compounds
AU2003246102A1 (en) * 2002-06-27 2004-01-19 Genox Research, Inc. Method of examining allergic disease and drug for treating the same
BR0312500B1 (pt) * 2002-07-10 2013-12-03 Uso cosmético de derivados de merocianina e preparação cosmética
JP2004155681A (ja) * 2002-11-05 2004-06-03 Lion Corp 口腔バイオフィルム抑制剤および口腔用組成物
KR20100075870A (ko) 2007-09-28 2010-07-05 다우 코닝 코포레이션 아스코브산의 에스터 유도체를 함유하는 오가노실록산

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0487404A1 (en) 1990-11-19 1992-05-27 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo External dermatological composition
WO1993004665A1 (fr) 1991-08-29 1993-03-18 L'oreal Composition cosmetique filtrante contenant un polymere filtre liposoluble a structure hydrocarbonee et une silicone filtre
DE4308282A1 (de) 1993-03-16 1994-09-22 Beiersdorf Ag Vorzugsweise in Form von Mikrosphärulen vorliegende galenische Matrices
WO1996009807A1 (de) 1994-09-27 1996-04-04 Henkel Kommanditgesellschaft Auf Aktien 2-hydroxy-1-ethanon-derivate zum färben keratinhaltiger fasern
DE19704273A1 (de) 1996-03-08 1997-09-11 Basf Ag Verfahren zur katalytischen Herstellung von optisch aktiven Hydroxyketonen
DE10133202A1 (de) 2001-07-07 2003-01-16 Beiersdorf Ag Osmolyte enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
EP1508327A1 (de) 2003-08-18 2005-02-23 MERCK PATENT GmbH Verwendung von Chromen-4-on-Derivaten zur Haut- oder Haarpflege
WO2006111234A1 (de) 2005-04-19 2006-10-26 Merck Patent Gmbh Uv schutz
WO2006111233A1 (de) 2005-04-19 2006-10-26 Merck Patent Gmbh Antioxidantien

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
J. Pharm, 115, 61-67 (1995)
Khwaja et al. (1997) EMBO 16: 2783
Lemanska et al., Current Topics in Biophysics 2000, 24 (2), 101-108
Lemanska et al., Free Radical Biology & Medicine 2001, 31 (7), 869-881
Rice-Evans et al., Trends in Plant Science 1997, 2 (4), 152-159
Stephens et al. (2000) Biochemical J 351: 95
White et al. (2001) Oncogene 20: 7064

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014139756A3 (de) * 2013-03-11 2014-12-18 Beiersdorf Ag Verwendung kosmetisch oder dermatologisch un­bedenk­licher substituierter michael-akzeptoren zur verhinderung, verminderung oder prophylaxe der tyrosinaseaktivität der menschlichen haut und/oder deren aufhellung
CN105050663A (zh) * 2013-03-11 2015-11-11 拜尔斯道夫股份有限公司 美容和皮肤病学上安全的取代迈克尔受体防止、降低或预防人类皮肤酪氨酸酶活性和/或亮肤的用途

Also Published As

Publication number Publication date
EP2616040B1 (de) 2014-10-22
EP2616040A1 (de) 2013-07-24
WO2012034629A1 (de) 2012-03-22
JP5731653B2 (ja) 2015-06-10
US8906351B2 (en) 2014-12-09
US20130164230A1 (en) 2013-06-27
CN103179948A (zh) 2013-06-26
JP2013537205A (ja) 2013-09-30

Similar Documents

Publication Publication Date Title
EP2648689B1 (de) 2-pyrone
EP3663366B1 (de) Verwendung physiologischer kühlwirkstoffe und mittel enthaltend solche wirkstoffe
EP2616040B1 (de) 2,2'-furoin-derivate und deren verwendung zur hautaufhellung
EP1979337A1 (de) Chromen-4-on-derivate als selbstbräunungssubstanz
EP2175936A1 (de) Tyrosinaseinhibitoren
EP2665717B1 (de) 7-acyloxy-chromen-4-on-derivate und ihre verwendung als selbstbräunungssubstanzen
WO2012007095A2 (de) Bräunungsverstärker und selbstbräunungssubstanzen
EP3402576B1 (de) Noreugenin-glykosid-derivate
DE102011102824A1 (de) Extrakte aus Eugenia uniflora
EP2229169A1 (de) Zubereitung enthaltend chroman-2-on-derivate
EP1566175B1 (de) Topische Zubereitung, enthaltend mindestens ein Aryloxim und Bisabolol
DE102010026775A1 (de) Bräunungsverstärker
WO2013020624A1 (de) Extrakte aus tradescantia virginiana
DE102010051689A1 (de) Dihydroxyfumarsäure-Derivate und deren Verwendung zur Hautaufhellung
EP2709731B1 (de) Extrakte aus darlingtonia californica
EP2775996B1 (de) Verwendung von propanol- und propenolderivaten als antioxidantien
EP2600854B1 (de) Phenethyl-, phenethylen-, phenetin- und indanonderivate
DE102010023507A1 (de) UV-Filter
WO2009021590A1 (de) Tyrosinaseinhibitoren

Legal Events

Date Code Title Description
R119 Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee

Effective date: 20130403